BBIO - Bridgebio Pharma, Inc. - Insider Stock Trading

Filing Date	T Date	Ticker	Sector	Ind	Industry	Owner	oSt	Rel	Title	#f	T	TVal	Price	Qty	Own	H
7/3/25 16:30	7/1/25	BBIO	Health	Drug	Pharmaceutical Preparations	Kumar Neil	CA	DO	CEO	9	S.dm	-38,847	35.56	-1,092	6,906	I
7/1/25 19:48	6/27/25	BBIO	Health	Drug	Pharmaceutical Preparations	Viking Global Investors LP	CT	T		2	S	-260,990	39.75	-6,566	22,055	I
6/30/25 17:51	6/26/25	BBIO	Health	Drug	Pharmaceutical Preparations	Valantine Hannah	CA	D		3	S.d	-799	36.50	-22	8	M
6/26/25 17:08	6/24/25	BBIO	Health	Drug	Pharmaceutical Preparations	McCormick Frank	CA	D		1	S	-4,423	44.23	-100	963	I
5/14/25 17:24	5/12/25	BBIO	Financ	InvAdv	Investment Advice	Kkr Genetic Disorder L.P.	NY	T		3	S	-552,310	31.03	-17,800	25,261	I
5/6/25 16:45	5/2/25	BBIO	Health	Drug	Pharmaceutical Preparations	Apuli Maricel	CA	O	Chief Ac	1	S	-40	38.51	-1	148	D
5/6/25 16:42	5/2/25	BBIO	Health	Drug	Pharmaceutical Preparations	Lo Andrew	CA	D		1	S	-3,850	38.50	-100	154	I
4/16/25 17:39	4/14/25	BBIO	Health	Drug	Pharmaceutical Preparations	Ellis Andrea	CA	D		2	S.d	-1,372	34.29	-40	12	D
2/27/25 17:36	2/25/25	BBIO	Health	Drug	Pharmaceutical Preparations	Stephenson Brian C	CA	O	CFO,Trea	5	S.d	-3,096	34.80	-89	102	D
6/5/24 16:53	6/3/24	BBIO	Health	Drug	Pharmaceutical Preparations	Scott Randal W.	CA	D		1	S.m	-76	30.32	-3	9	I

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person